Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells

European Journal of Immunology

Volumn 29, Issue 3, 1999, Pages 964-972

  Zhong, Lei ^a   Granelli Piperno, Angela ^a   Choi, Yongwon ^a   Steinman, Ralph M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Adenovirus; Dendritic cell; Immunotherapy; Maturation; Transfection

Indexed keywords

CD83 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ADENOVIRUS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; TRANSGENE; VIRUS RECOMBINANT;

EID: 0032984602     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-4141(199903)29:03<964::aid-immu964>3.0.co;2-p     Document Type: Article

References (37)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ilstad, S. T., Kast, W. M., DeLeo, A. B. and Lotze, M. T., Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1995. 1: 1297-1302.
3. Fields, R. C., Shimizu, K. and Mule, J. J., Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 1998. 95: 9482-9487.
4. Su, H., Messer, R., Whitmire, W., Fischer, E., Portis, J. C. and Caldwell, H. D., Vaccination against chlamydial genital tract infection following immunization with dendritic cells pulsed ex vivo with non-viable chlamydiae. J. Exp. Med. 1998. 188: 809-818.
5. Ludewig, B., Ehl, S., Karrer, U., Odermatt, B., Hengartner, H. and Zinkernagel, R. M., Dendritic cells efficiently induce protective antiviral immunity. J. Virol. 1998. 272: 3812-3818.
6. Song, W., Kong, H., Carpenter, H., Torii, H., Granstein, R., Rafii, S., Moore, M. A. S. and Crystal, R. G., Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model tumor antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 1997. 186: 1247-1256.
7. Specht, J. M., Wang, G., Do, M. T., Lam, J. S., Royal, R. E., Reeves, M. E., Rosenberg, S. A. and Hwu, P., Dendritic cells retrovirally transduced with a model tumor antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 1997. 186: 1213-1221.
8. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G. and Schadendorf, D., Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med. 1998. 4: 328-332.
9. De Bruijn, M. L., Schuurhuis, D. H., Vierboom, M. P., Vermeulen, H., de Cock, K. A., Ooms, M. E., Ressing, M. E., Toebes, M., Franken, K. L., Drijfhout, J. W., Ottenhoff, T. H., Offringa, R. and Melief, C. J., Immunization with human papillomavirus type 16 (HPV 16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV-16 induced tumor cells. Cancer Res. 1998. 58: 724-731.
10. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 1994. 179: 1109-1118.
11. Romani, N., Reider, D., Heuer, M., Ebner, S., Eibl, B., Niederwieser, D. and Schuler, G., Generation of mature dendritic cells from human blood: An improved method with special regard to clinical applicability. J. Immunol. Methods 1996. 196: 137-151.
12. Bender, A., Sapp, M., Schuler, G., Steinman, R. M. and Bhardwaj, N., Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 1996. 196: 121-135.
13. Wan, Y., Bramson, J., Carter, R., Graham, F. and Gauldie, J., Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination. Hum. Gene Ther. 1997. 8: 1355-1363.
14. Ribas, A., Butterfield, L. H., McBride, W. H., Jilani, S. M., Bui, L. A., Vollmer, C. M., Lau, R., Dissett, V. B., Hu, B., Chen, A. Y., Glaspy, J. A. and Economou, J. S., Genetic immunization for the melanoma antigen MART-1/melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res. 1997. 57: 2865-2869.
15. Dietz, A. B. and Vuk-Pavlovic', S., High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood 1998. 91: 392-398.
16. Cella, M., Sallusto, F. and Lanzavecchia, A., Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 1997. 9: 10-16.
17. Routes, J. M., Metz, B. A. and Cook, J. L., Endogenous expressions of E1A in human cells enhances the effect of adenovirus E3 on class I major histocompatibility complex antigen expression. J. Virol. 1993. 67: 3176-3181.
18. Körner, H. and Burgert, H. G., Down-regulation of HLA antigens by the adenovirus type 2 E3/19K protein in a T lymphoma cell line. J. Virol. 1994. 68: 1442-1448.
19. + T cells. J. Immunol. 1995. 154: 5071-5079.
20. Koch, F., Stanzl, U., Jennewien, P., Janke, K., Heufler, C., Kampgen, E., Romani, N. and Schuler, G., High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [Published erratum appears in J. Exp. Med. 1996. 184: 1590ff.]. J. Exp. Med. 1996. 184: 741-746.
21. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747-752.
22. Wong, B. R., Josien, R., Lee, S. Y., Sauter, B., Li, H., Steinman, R. M. and Choi, Y., TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell specific survival factor. J. Exp. Med. 1997. 186: 2075-2080.
23. + cells. Gene Ther. 1998. 5: 465-472.
24. Arthur, J. F., Butterfield, L. H., Roth, M. D., Bui, L. A., Kiertscher, S. M., Lau, R., Dubinett, S., Glaspy, J., McBride, W. H. and Economou, J. S., A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 1997. 4: 17-25.
25. Mulders, P., Pang, S., Dannull, J., Kaboo, R., Hinkel, A., Michel, K., Tso, C.-L., Roth, M. and Belldegrun, A., Highly efficient and consistent gene transfer into dendritic cells utilizing a combination of ultraviolet-irradiated adenovirus and poly(L-Lysine) conjugates. Cancer Res. 1998. 58: 956-961.
26. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 1998. 188: 1359-1368.
27. 5 promote adenovirus internalization but not virus attachment. Cell 1993. 73: 309-319.
28. Szabolcs, P., Gallardo, H. F., Ciocon, D., Sadelain, M. and Young, J. W., Retrovirally transduced human dendritic cells express a normal phenotype and potent T cell stimulatory capacity. Blood 1997. 90: 2160-2167.
29. Aicher, A., Westermann, J., Cayeux, S, Willimsky, G., Daemen, K., Blankenstein, T., Uckert, W., Dorken, B. and Pezzutto, A., Successful retroviral mediated transduction of a reporter gene in human dendritic cells: Feasibility of therapy with gene-modified antigen presenting cells. Exp. Hematol. 1997. 25: 39-44.
30. Reeves, M. E., Royal, R. E., Lam, J. S., Rosenberg, S. A. and Hwu, P., Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 1996. 56: 5672-5677.
31. ++ human cord blood cell generate T cells expressing high levels of the retroviral encoded green fluorescent protein marker in vitro. Blood 1998. 91: 431-440.
32. Christ, M., Lusky, M., Stoeckel, F., Dreyer, D., Dieterle, A., Michou, A. I., Pavirani, A. and Mehtali, M., Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response. Immunology 1997. 57: 19-25.
33. Van Ginkel, F. W., McGhee, J. R., Liu, C., Simecka, J. W., Yamamoto, M., Frizzell, R. A., Sorscher, E. J., Kiyono, H. and Pascual, D. W., Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene. J. Immunol. 1997. 159: 685-693.
34. Chirmule, N., Hughes, J. V., Gao, G.-P., Raper, S. E. and Wilson, J. M., Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J. Virol. 1998. 72: 6138-6145.
35. Gao, G. P., Yang, Y. and Wilson, J. M., Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 1996. 70: 8934-8943.
36. Molnar-Kimber, K. L., Sterman, D. H., Chang, M., Kang, E. H., Elbash, M., Lanuti, M., Elshami, A., Gelfrand, K., Wilson, J. M., Kaiser, L. R. and Albelda, S. M., Impact of preexisting and induced humoral and cellular immune responses in an adenovirus-based gene therapy phase I clinical trial for localized mesothelioma. Hum. Gene Ther. 1998. 9: 2121-2133.
37. Schuler, M., Rochlitz, C., Horowitz, J. A., Schlegel, J., Perruchoud, A. P., Kommoss, F., Bolliger, C. T., Kauczor, H. U., Dalquen, P., Fritz, M. A., Swanson, S., Herrmann, R. and Huber, C., A phase I study of adenovirus-medicated wild-type p53 gene transfer in patients with advanced non-small cell lung cancer. Hum. Gene Ther. 1998. 9: 2075-2082.